Loading clinical trials...
Loading clinical trials...
This study was a retrospective observational study. The study included patients with non-small cell lung cancer with ALK-fusion brain metastases or meningeal metastases who received first-line and lat...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sichuan Cancer Hospital and Research Institute
NCT07462507 · Central Nervous System Cancer, Brain Metastases
NCT06253871 · HER2 Mutation-Related Tumors, HER2, and more
NCT05987644 · Lung Cancer, NSCLC, and more
NCT05692635 · Brain Metastases, Nonsmall Cell Lung Cancer Stage III
NCT07130786 · Seizures, Primary Motor Cortex, and more
Sichuan cancer hospital
Chengdu, Sichuan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions